Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000075

SVP, GEN COUNSEL & CORP SEC sold 5,500 shares at an average $114.24 ($628,295)

  • SVP, GEN COUNSEL & CORP SEC acquired 5,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-01 Option exercise 10b5-1 +5,500 $21.41 $117,755 34,123 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-01 Sale 10b5-1 −1,414 $113.38 $160,321 32,709 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-01 Sale 10b5-1 −3,056 $114.37 $349,512 29,653 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-01 Sale 10b5-1 −1,030 $115.01 $118,462 28,623 D
Derivatives
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-10-01 Option exercise · Stock Option (right to buy) 10b5-1 −5,500 174,497 D
Open-market sales · 5,500 sh · avg $114.24 · $628,295
Loading xslF345X05/wk-form4_1727986533.xml…